✦ LIBER ✦

Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer

✍ Scribed by Mari Nakabayashi; Lilian Werner; Kevin D. Courtney; Geoffrey Buckle; William K. Oh; Glen J. Bubley; Julia H. Hayes; Douglas Weckstein; Aymen Elfiky; Danny M. Sims; Philip W. Kantoff; Mary-Ellen Taplin

Book ID: 117949770
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 225 KB
Volume: 110
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2012.11456.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Trial of Bortezomib and Predn

A Phase II Trial of Bortezomib and Prednisone for Castration Resistant Metastatic Prostate Cancer

✍ Morris, Michael J.; Kelly, W. Kevin; Slovin, Susan; Ryan, Charles; Eicher, Caitl 📂 Article 📅 2007 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 304 KB

Phase II Trial of Capecitabine and Weekl

Phase II Trial of Capecitabine and Weekly Docetaxel for Metastatic Castrate Resistant Prostate Cancer

✍ Vaishampayan, Ulka N.; Marur, Shanthi; Heilbrun, Lance K.; Cher, Michael L.; Dic 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 480 KB

Final analysis of a phase II trial using

Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer

✍ Jeanny B. Aragon-Ching; Lokesh Jain; James L. Gulley; Philip M. Arlen; John J. W 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

A Phase II Study of GW786034 (Pazopanib)

A Phase II Study of GW786034 (Pazopanib) With or Without Bicalutamide in Patients With Castration-Resistant Prostate Cancer

✍ Sridhar, Srikala S.; Joshua, Anthony M.; Gregg, Richard; Booth, Christopher M.; 📂 Article 📅 2015 🏛 CIG Media Group, LP. 🌐 English ⚖ 114 KB

A phase II study of sorafenib in combina

A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancer

✍ Emma K. Beardsley, Sebastien J. Hotte, Scott North, Susan L. Ellard, Eric Winqui 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 210 KB

Phase II trial of cisplatin plus prednis

Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients

✍ Carlo Buonerba; Piera Federico; Carmine D’Aniello; Pasquale Rescigno; Carla Cava 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 180 KB